Scott Damrauer Profile
Scott Damrauer

@damrauer

Followers
453
Following
462
Media
20
Statuses
101

Vascular Surgeon and Scientist at the University of Pennsylvania and CMC (Philadelphia) VA Medical Center. Views are my own.

Joined April 2013
Don't wanna be here? Send us removal request.
@damrauer
Scott Damrauer
2 years
It was great to be able discuss the future of precision medicine and vascular disease @VascularCures #VascSummit23. A special thanks to Ken Tran @StanfordVasc for allowing me to share some of the amazing work he is doing on aortic modeling.
@VascularCures
Foundation to Advance Vascular Cures
2 years
A groundbreaking model shared by @damrauer: The future of precision medicine for therapeutic selection lies in computer simulations, tailoring therapies based on each patient's unique anatomy & physiology. #VascSummit23 #PrecisionMedicine #VascSurg
1
2
17
@damrauer
Scott Damrauer
2 years
It was a privilege to be the Baszucki Visiting Professor and learn about the exciting research @StanfordVasc. The depth and breath of the work is truly amazing!
@StanfordVasc
Stanford Vascular
2 years
It was an honor to host @damrauer as our visiting professor for Stanford Vascular Surgery's Baszucki Research Day, celebrating the opening of the Baszucki Bio Bank. @StanfordSurgery @dmklarin @Nazish_Sayed https://t.co/Xr2MtdniVc
1
0
17
@AlexBickMDPhD
Alex Bick
2 years
What can we learn from >350 billion genetic variant-trait associations across diverse individuals? Proud play a small role in this monumental @VAResearch effort 4+ years in the making led by @_anuragverma @JennyGenetics @madduri, @damrauer & @kat_liao https://t.co/7oDIxWmd5e
Tweet card summary image
medrxiv.org
Genome-wide association studies (GWAS) have underrepresented individuals from non-European populations, impeding progress in characterizing the genetic architecture and consequences of health and...
1
11
45
@mendel_random
george davey smith
4 years
I’m talking on "Human genetics and phenotypic causality: a historical introduction" @uclbiosciences on the 16th March 3pm, from Darwin through Sewall Wright and R A Fisher up to contemporary Mendelian randomization approaches https://t.co/b8AKcFIrKm
1
3
17
@tassimes
Tim L. Assimes, MD PhD
4 years
Our latest MVP research findings co-led with @JennyGenetics and Yan Sun: Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program
Tweet card summary image
frontiersin.org
SARS-CoV-2 has caused symptomatic COVID-19 and widespread death across the globe. We sought to determine genetic variants that contribute to COVID-19 suscept...
1
3
17
@pnatarajanmd
Pradeep Natarajan
4 years
Excited to share our collaboration with @drmalissawood @MarkELindsay led by @zekavatm @LizChou using human genetics and complementary murine models describing the role of fibrillar collagen variants in spontaneous coronary artery dissection https://t.co/1davmmGOU6 @JAMACardio
2
13
65
@damrauer
Scott Damrauer
4 years
Excited to share our varicose veins GWAS from VA Million Veteran Program highlighting the role of inflammation, vascular remodeling, and angiogenesis. A great collaboration between @VAResearch & @ORNL @argonne @ENERGY scientists. https://t.co/Fsppt1Dbtj
0
15
30
@damrauer
Scott Damrauer
6 years
This is a real honor and testimony to strong, collaborative @VAResearch. Thanks to our great collaborators: @tassimes @MGLevin @AeronSmallMD @skathire @VujkovicM @chrisodmd @JennyGenetics @ShipraAryaMD @amitvkhera @DuVallScott @bvoight28 @pennsurgery @PennGenetics and others
@pnatarajanmd
Pradeep Natarajan
6 years
Very exciting that our @VAResearch genetic studies led by D. Klarin for venous thromboembolic disease & peripheral arterial disease are highlighted here! @AHAScience @GenPrecisionMed @skathire @damrauer @MGH_RI @MGHHeartHealth @broadinstitute
1
3
32
@damrauer
Scott Damrauer
6 years
Great work by @MGLevin @PennCardiology @PennGenetics. Thanks to all our collaborators for helping with what has been a very interesting project.
@MGLevin
Michael Levin
6 years
Ending the year (and decade!) with a new preprint in @medrxivpreprint - Genetics of Height and Risk of Atrial Fibrillation: A Mendelian Randomization Study https://t.co/7uMpSx8VgI #EPeeps #cardiotwitter
0
0
8
@Mendelian_lit
MR_lit
6 years
Mendelian randomisation for mediation analysis: current methods and challenges for implementation
0
10
44
@damrauer
Scott Damrauer
6 years
Great talk by @NganHuang discussing strategies to improve survival of iPSC derived EC to improve outcomes for limb ischemia.
@SeanM_Wu
Sean M Wu, MD PhD
6 years
Nguni Huang @StanfordCVI & CT Surgery Dept discusses the used of iPSC-derived Endothelial cells to treat hindlimb ischemia model of PAD at #stanfordpenn2019 @StanfordMed @stanford Poor cell survival after transplant provides the impetus for developing new ECM biomaterials.
0
0
3
@tyingwithpolish
Elsie Ross
6 years
A huge thank you to @StanfordCVI and the NIH FOCUS program @UCSDfacaffairs for providing seed funding to support my vision for precision health for vascular disease! Will earlier, automated diagnosis lead to less life/limb loss -> lower health care costs -> 🌈 & 🦄?
1
4
18
@SeanM_Wu
Sean M Wu, MD PhD
6 years
Shipra Arya @StanfordMed vascular surgery discuss the EVAR revolution to replace open AAA repair with stents, fenestrated and branch grafts at #stanfordpenn2019 A major change in ways that vascular surgeons are being trained now. @StanfordDeptMed @StanfordCVI @stanford
0
3
12
@damrauer
Scott Damrauer
6 years
Reinterventions for EVAR add significant costs in the long term. And more complex repairs have more complex modes of failure and require more complex reintwrventions.
0
1
5
@damrauer
Scott Damrauer
6 years
Vascular surgeon @ShipraAryaMD talks about advanced EVAR and the growth in utilization at #stanfordpenn2019 CVI symposium. @StanfordCVI @stanfordvasc
1
2
15
@damrauer
Scott Damrauer
6 years
More evidence to suggest the role of Factor V Leiden and other inherited thrombophilias in arterial thrombosis. Nice study from @CukerMd @PennMedicine in @JAHA_AHA showing increased risk of stroke in FVL carriers based on meta-analysis.
Tweet card summary image
ahajournals.org
0
1
0
@skathire
Sek Kathiresan MD
6 years
Here's another story of developing a medicine that mimics human protective mutations. Follow along.
@Regeneron
Regeneron
6 years
Our Phase 3 clinical trial for patients with a severe, inherited form of #highcholesterol met its primary endpoint. Read more: https://t.co/OLGOCitPPW
3
61
147
@ColemanDM_vasc
Dawn Coleman
6 years
An amazing surgeon scientist and wonderful human!! Grateful for @ShereneShalhub and all the good she does for so many complex #vascularsurgery patients and our specialty!!
@VESurgery
VESurgery
6 years
Go check out our “member of the month” @ShereneShalhub at https://t.co/YgUuft19ot
1
2
16